PostHeaderIcon H1N1 flu vaccination in US starts in October



With the onset of school, health experts fear that the spread of the swine flu will intensify. That’s why they plan to start the vaccination in about three weeks to protect as much individuals as possible to the pandemic virus.

Earlier, it was thought that the new H1N1 flu virus would need a two step dosing to achieve a level of immunity during the vaccination, but recent studies on patients with ages 18 to 64 years showed that a single dose containing 15 micrograms of the viral antigen was enough to stimulate protective levels of antibodies. From the initial results, the vaccine which didn’t contain adjuvant to boost its efficacy, showed no serious side-effects.

“The results of the vaccine studies suggest one dose of the formula used by drugmakers should offer H1N1 protection similar to the seasonal flu shot. Paris-based Sanofi Aventis SA, London- based GlaxoSmithKline Plc, and Basel, Switzerland-based Novartis AG are among the other companies making the vaccine. “---- Bloomberg.com (09/13/09, Randall, T; Gale, J.)

The single dose regimen will simplify the vaccination process and appreciably increase the production and stockpile of Paris-based Sanofi Aventis SA, London- based GlaxoSmithKline Plc, and Basel, Switzerland-based Novartis AG which are making the vaccines. There are plans in the US to donate prepared vaccines to poor countries. Since the experience their use is limited, more studies are needed to validate the initial findings to ascertain the efficacy and safety of the drug. (Photo Credit: CDC) =0=

==========================================================

Blog Archive

Topics/Categories

Feedjit Live Blog Stats

Topics/Categories

Add to Technorati Favorites

Ateneo de Naga HS Batch 74

ABS-CBN News

GMA News.tv

Philippine Commentary

Inquirer Breaking News